Clinical and Biochemical Aspects of the Development of Chronic Viral Hepatitis with a Comorbid Course of Chronic Glomerulonephritis
Keywords:
Chronic Glomerulonephritis, Chronic Hepatitis B, Hepatitis C, Autoantibody
Abstract
In viral hepatitis, secondary glomerular lesions are slow, but in one third of patients, this process develops steadily and manifests itself as a nephrotic syndrome, worsening the patient's condition with the manifestation of renal failure. The purpose of this study is to examine the clinical and biochemical aspects of damage to the functional state of the kidneys in chronic viral Hepatitis B and C. The study involved 198 patients with positive HBV and HCV serological markers and clinical and laboratory syndromes of kidney damage.
References
1. N.Sh. Akhmedova, K.Zh. Boltaev. The role of laboratory and functional examination of the primary health care system. Problems of biology and medicine, 2015. - No. 4 (85). – p.53
2. V.Sh. Rakhimova, I.N. Egamova. Extrahepatic manifestations of chronic viral hepatitis C. Journal of Hepato- Gastroenterological Research Vol. 1 No. 1 (2020). pp. 78-82
3. N.K. Khamidova, N.Sh. Akhmedov. Features and approaches to the treatment of hyperlipidemia in various clinical forms of glomerulonephritis. Infection, Immunity and Pharmacology 2017- №2 - pp. 243-246
4. N.Sh. Akhmedova. The importance jf proteinuria as a predictor of diagnosis and a factor for the development of chronic kidney disease// European science review –Vienna- 2018-№ 7-8 p 84-85
5. S.M. Alavian, S.V. Tabatabaei. Metaanalysis of factors associated with sustained viral response in patients on hemodialysis treated with standard or pegylated interferon for hepatitis C infection // Iran J. Kidney Dis. 2010; 4: 18194. 6. Kahloun A, Babba T, Fathallah B, Ghozzi M, Ezzine H, Said Y, Azzouz MM. Prevalence of extra-hepatic manifestations in infection with hepatitis C virus: study of 140 cases // Tunis Med. 2011 Jun;89(6): 557-60.
6. O.V. Tirikova, I.A. Filatova Glomerulonephritis. Tutorial. Federal State Budgetary Educational Institution of Higher Education IRKUTSK STATE MEDICAL UNIVERSITY" of the Ministry of Health of Russia, 2017.
7. S. Radhakrishnan, A. Lunn, M. Kirschfink, et al. Eculizumab and refractory membranoproliferative glomerulonephritis. N Engl J Med 2012; 366:1165.
2. V.Sh. Rakhimova, I.N. Egamova. Extrahepatic manifestations of chronic viral hepatitis C. Journal of Hepato- Gastroenterological Research Vol. 1 No. 1 (2020). pp. 78-82
3. N.K. Khamidova, N.Sh. Akhmedov. Features and approaches to the treatment of hyperlipidemia in various clinical forms of glomerulonephritis. Infection, Immunity and Pharmacology 2017- №2 - pp. 243-246
4. N.Sh. Akhmedova. The importance jf proteinuria as a predictor of diagnosis and a factor for the development of chronic kidney disease// European science review –Vienna- 2018-№ 7-8 p 84-85
5. S.M. Alavian, S.V. Tabatabaei. Metaanalysis of factors associated with sustained viral response in patients on hemodialysis treated with standard or pegylated interferon for hepatitis C infection // Iran J. Kidney Dis. 2010; 4: 18194. 6. Kahloun A, Babba T, Fathallah B, Ghozzi M, Ezzine H, Said Y, Azzouz MM. Prevalence of extra-hepatic manifestations in infection with hepatitis C virus: study of 140 cases // Tunis Med. 2011 Jun;89(6): 557-60.
6. O.V. Tirikova, I.A. Filatova Glomerulonephritis. Tutorial. Federal State Budgetary Educational Institution of Higher Education IRKUTSK STATE MEDICAL UNIVERSITY" of the Ministry of Health of Russia, 2017.
7. S. Radhakrishnan, A. Lunn, M. Kirschfink, et al. Eculizumab and refractory membranoproliferative glomerulonephritis. N Engl J Med 2012; 366:1165.
Published
2022-05-21
How to Cite
Yoqub o‘g‘li, M. S., & Abdurasulovich, S. S. (2022). Clinical and Biochemical Aspects of the Development of Chronic Viral Hepatitis with a Comorbid Course of Chronic Glomerulonephritis. Central Asian Journal of Medical and Natural Science, 3(3), 121-125. https://doi.org/10.17605/cajmns.v3i3.741
Issue
Section
Articles
